Farther Finance Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.3K | Buy |
615
+392
| +176% | +$59.5K | ﹤0.01% | 1786 |
|
|
2025
Q1 | $32.6K | Buy |
223
+69
| +45% | +$10.1K | ﹤0.01% | 2121 |
|
|
2024
Q4 | $28.4K | Buy |
154
+17
| +12% | +$3.14K | ﹤0.01% | 1924 |
|
|
2024
Q3 | $27K | Sell |
137
-89
| -39% | -$17.5K | ﹤0.01% | 1950 |
|
|
2024
Q2 | $45.9K | Buy |
226
+117
| +107% | +$23.8K | ﹤0.01% | 1455 |
|
|
2024
Q1 | $29.3K | Sell |
109
-81
| -43% | -$21.8K | ﹤0.01% | 1374 |
|
|
2023
Q4 | $44.9K | Buy |
190
+156
| +459% | +$36.9K | ﹤0.01% | 1072 |
|
|
2023
Q3 | $6.66K | Sell |
34
-22
| -39% | -$4.31K | ﹤0.01% | 1418 |
|
|
2023
Q2 | $11.8K | Buy |
56
+3
| +6% | +$631 | ﹤0.01% | 1143 |
|
|
2023
Q1 | $10.7K | Buy |
53
+16
| +43% | +$3.23K | ﹤0.01% | 1090 |
|
|
2022
Q4 | $8.06K | Buy |
+37
| New | +$8.06K | ﹤0.01% | 1015 |
|